MAPLE GROVE, Minn.--(BUSINESS WIRE)--NxThera, Inc., a privately held medical device company developing a proprietary water vapor endourology treatment platform, today announced that Steven Gange, MD, of Western Urological Clinic and Jean Brown Research in Salt Lake City, Utah, used NxThera’s Rezum® System to enroll and treat the first patients in NxThera’s Rezum II U.S. investigational device exemption (IDE) clinical trial for the treatment of benign prostatic hyperplasia (BPH). The Rezum System is designed to rapidly treat prostate tissue using sterile water vapor, or steam, in an office-based, minimally invasive procedure designed to treat the urethral obstruction caused by BPH.
Help employers find you! Check out all the jobs and post your resume.
